Skip to main content

Table 4 Cost per patient (€) the first, second and third year of diagnosis according to cancer type, 2012–2014, €1.00 = NOK 8.357a

From: The healthcare costs of treating human papillomavirus-related cancers in Norway

  Cost (€) per patient
Cancer diagnosis by year of treatmentb No. of patients Mean Std. Median
Cervical cancer
 1st 954 32,220 27,989 26,324
 Proportion of total cost first 3 years (%)    (90.71)   
 2nd 290 8989 20,572 892
 3rd 99 5436 13,660 375
 Total cost first 3 years 954 35,518 33,556 27,358
Vaginal cancer
 1st 28 30,210 15,234 30,971
 Proportion of total cost first 3 years (%)   (97.68)   
 2nd 7 2712 5747 500
 3rd 2 563 265 563
 Total cost first 3 years 28 30,928 15,352 33,782
Vulvar cancer
 1st 224 23,798 22,066 20,024
 Proportion of total cost first 3 years (%)   (90.61)   
 2nd 53 8550 18,035 731
 3rd 13 7655 12,501 487
 Total cost first 3 years 224 26,265 26,342 22,523
Penile cancer
 1st 141 16,085 21,828 8222
Proportion of total cost first 3 years (%)   (87.66)   
2nd 38 8311 21,397 713
3rd 9 396 119 356
Total cost first 3 years 141 18,350 26,245 8466
Anal cancer
 1st 330 26,876 25,934 21,692
 Proportion of total cost first 3 years (%)   (88.83)   
 2nd 111 8221 18,460 1426
 3rd 43 4720 11,079 951
 Total cost first 3 years 330 30,256 31,223 23,415
Oropharyngeal cancer
 1st 564 48,055 37,376 41,362
 Proportion of total cost first 3 years (%)   (96.55)   
 2nd 215 3965 11,619 536
 3rd 77 1515 8244 212
 Total cost first 3 years 564 49,774 39,737 41,651
  1. aThe patient population represent the incidence population
  2. bYear of treatment reflects treatment year